BioLine Rx (NASDAQ:BLRX) Azioni

BIOLINERX LTD-SPONS ADR

BioLine Rx

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

BioLineRx Ltd. - American Depositary Shares

BioLine Rx Ltd

<a href="https://ppubs.uspto.gov/api/pdf/downloadPdf/12291570?requestToken=eyJzdWIiOiJjOTQwM2FiZi00MjE0LTRkZjQtYTZlMC00NTE3NDcwOTMwZDUiLCJ2ZXIiOiI1YWY5ZWZhOC1mMDY4LTQ0M2UtYjQ1YS02MjgxYmJhMTYwMGIiLCJleHAiOjB9" title="https://ppubs.uspto.gov/api/pdf/downloadPdf/12291570?requestToken=eyJzdWIiOiJjOTQwM2FiZi00MjE0LTRkZjQtYTZlMC00NTE3NDcwOTMwZDUiLCJ2ZXIiOiI1YWY5ZWZhOC1mMDY4LTQ0M2UtYjQ1YS02MjgxYmJhMTYwMGIiLCJleHAiOjB9">https://ppubs.uspto.gov/api/pdf/downloadPdf/12291570?requestToken=eyJzdWIiOiJjOTQwM2FiZi00MjE0LTRkZjQtYTZlMC00NTE3NDcwOTMwZDUiLCJ2ZXIiOiI1YWY5ZWZhOC1mMDY4LTQ0M2UtYjQ1YS02MjgxYmJhMTYwMGIiLCJleHAiOjB9</a>

News

BLRX

BioLineRx Ltd., Merck Granted U.S. Patent #12291570	Treatment of metastatic pancreatic adenocarcinoma

<h3>Gainers</h3>
<ul>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares rose 65.3% to $1.67 during Friday's after-market session. The market value of their outstanding shares is at $66.4 million. </li>
<li>Tharimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THAR#NASDAQ">THAR</a>) stock moved upwards by 9.35% to $1.67. The market value of their outstanding shares is at $3.2 million. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) shares rose 7.45% to $0.27. The market value of their outstanding shares is at $22.6 million. </li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares moved upwards by 7.08% to $2.87. The market value of their outstanding shares is at $13.1 million. </li>
<li>BioVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) stock moved upwards by 6.66% to $1.28. The company's market cap stands at $23.6 million. </li>
<li>LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) stock moved upwards by 6.63% to $31.48. The market value of their outstanding shares is at $867.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares decreased by 24.2% to $0.39 during Friday's after-market session. The company's market cap stands at $9.0 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock declined by 15.75% to $0.63. The market value of their outstanding shares is at $7.2 million. </li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares decreased by 12.09% to $1.6. The company's market cap stands at $21.2 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) stock declined by 10.86% to $3.04. The company's market cap stands at $11.3 million. </li>
<li>Palisade Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares fell 8.63% to $0.74. The market value of their outstanding shares is at $3.4 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) stock declined by 7.4% to $0.6. The company's market cap stands at $3.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BCDA

BIVI

LENZ

PALI

PLRZ

PSTV

RNAZ

THAR

12 Health Care Stocks Moving In Friday's After-Market Session

Jones Trading analyst Justin Walsh downgrades BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) from Buy to Hold.

Downgrades

Analyst Ratings

Jones Trading Downgrades BioLine Rx to Hold

HC Wainwright &amp; Co. analyst Joseph Pantginis maintains BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) with a Buy and raises the price target from $9 to $26.

Price Target

HC Wainwright & Co. Maintains Buy on BioLine Rx, Raises Price Target to $26

<h3>Companies Reporting Before The Bell</h3>
• Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) is estimated to report quarterly loss at $1.36 per share on revenue of $2.69 million. 
• ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) is likely to report quarterly loss at $0.24 per share on revenue of $3.77 million. 
• Synergy CHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNYR#NASDAQ">SNYR</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $10.55 million. 
• Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $70.35 million. 
• Loar Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOAR#NYSE">LOAR</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $102.51 million. 
• Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) is expected to report earnings for its fourth quarter. 
• Edible Garden (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) is estimated to report quarterly loss at $9.00 per share on revenue of $4.12 million. 
• Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $16.98 million. 
• Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) is expected to report earnings for its fourth quarter. 
• FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) is projected to report quarterly loss at $0.84 per share on revenue of $11.61 million. 
• Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $77.16 million. 
• Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) is expected to report quarterly loss at $4.38 per share on revenue of $3.06 million. 
• LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) is estimated to report quarterly loss at $1.67 per share on revenue of $1.50 million. 
• Data Storage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTST#NASDAQ">DTST</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $6.20 million. 
• BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $7.72 million. 
• IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) is estimated to report quarterly loss at $0.39 per share on revenue of $10.43 million. 
• LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) is expected to report quarterly loss at $0.14 per share on revenue of $23.55 million. 
• Palvella Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PVLA#NASDAQ">PVLA</a>) is likely to report earnings for its fourth quarter. 
• Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) is expected to report quarterly loss at $0.15 per share on revenue of $3.80 million. 
• Chicago Atlantic BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIEN#NASDAQ">LIEN</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $11.00 million. 
• BOS Better Online Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>) is likely to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• T Stamp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) is projected to report quarterly loss at $1.80 per share on revenue of $510 thousand. 
• Local Bounti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOCL#NYSE">LOCL</a>) is expected to report quarterly loss at $3.89 per share on revenue of $10.95 million. 
• Vivos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) is estimated to report quarterly loss at $0.43 per share on revenue of $3.89 million. 
• Siyata Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) is projected to report earnings for its fourth quarter. 
• Open Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $24.03 million. 
• Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $81.13 million. 
• Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) is expected to report earnings for its fourth quarter. 
• CXApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXAI#NASDAQ">CXAI</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $2.00 million. 
• Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) is projected to report earnings for its fourth quarter. 
• Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) is projected to report earnings for its Fiscal Year 2024. 
• Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is expected to report earnings for its fourth quarter. 
• Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) is estimated to report earnings for its fourth quarter. 
• Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $92.50 million. 
• Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) is estimated to report quarterly loss at $0.16 per share on revenue of $3.90 million. 
• Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) is projected to report quarterly loss at $0.09 per share on revenue of $7.49 million. 
• Digi Power X (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGXX#NASDAQ">DGXX</a>) is likely to report quarterly loss at $0.12 per share on revenue of $14.30 million. 
• Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) is projected to report earnings for its fourth quarter. 
• Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) is likely to report earnings for its fourth quarter. 
• VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) is projected to report quarterly loss at $0.05 per share on revenue of $545 thousand. 
• iShares Gold Trust Shares of the iShares Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAU#NYSE">IAU</a>) is projected to report quarterly loss at $0.02 per share on revenue of $37.70 million. 
• i-80 Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IAUX#AMEX">IAUX</a>) is projected to report earnings for its fourth quarter. 
• Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) is expected to report earnings for its fourth quarter. 
• Wrap Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRAP#NASDAQ">WRAP</a>) is likely to report earnings for its fourth quarter. 
• MDB Capital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDBH#NASDAQ">MDBH</a>) is estimated to report earnings for its fourth quarter. 
• Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) is expected to report quarterly loss at $0.34 per share on revenue of $1.60 million. 
• Dare Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) is likely to report quarterly loss at $0.63 per share on revenue of $1.00 million. 
• Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) is projected to report earnings for its fourth quarter. 
• CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) is likely to report quarterly loss at $0.07 per share on revenue of $9.43 million. 
• Venu Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VENU#AMEX">VENU</a>) is expected to report earnings for its fourth quarter. 
• Alpha Cognition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>) is estimated to report earnings for its fourth quarter. 
• ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) is projected to report quarterly loss at $1.33 per share on revenue of $6.30 million. 
• Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) is estimated to report earnings for its fourth quarter. 
• Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) is projected to report earnings for its fourth quarter. 
• Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) is projected to report quarterly loss at $0.96 per share on revenue of $1.70 million. 
• CaliberCos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWD#NASDAQ">CWD</a>) is likely to report quarterly loss at $0.04 per share on revenue of $6.69 million. 
• Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) is expected to report earnings for its fourth quarter. 
• Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) is projected to report quarterly earnings at $1.39 per share on revenue of $234.69 million. 
• PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is likely to report quarterly earnings at $3.24 per share on revenue of $2.34 billion. 
• Invesco National AMT-Free Municipal Bond ETFo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZA#NYSE">PZA</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $168.10 million. 
• BioHarvest Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHST#NASDAQ">BHST</a>) is likely to report earnings for its fourth quarter. 
• Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) is projected to report quarterly loss at $0.01 per share on revenue of $212.30 million. 
• Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) is expected to report quarterly loss at $8.40 per share on revenue of $6.30 million. 
• Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) is likely to report earnings for its fourth quarter. 
• TechTarget (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) is expected to report quarterly earnings at $0.45 per share on revenue of $62.37 million. 
• Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) is expected to report quarterly loss at $0.08 per share on revenue of $12.91 million. 
• Flexible Solutions Intl (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FSI#AMEX">FSI</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $10.83 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ACOG

AQMS

BCLI

BHST

BNGO

BOSC

CELC

CRIS

CTSO

CXAI

DARE

DGXX

DTST

DUOT

EDBL

FTCI

GORV

GRRR

GRYP

IAUX

IDAI

IMCC

LIEN

LMFA

LNZA

LOAR

LOCL

LPRO

MDBH

MVST

NNOX

NSYS

NUTX

NVVE

OMER

PRGS

PRPH

PRPO

PVLA

PowerShares Insured Municipal Bond Portfolio

RANI

RCAT

REKR

SGML

SIDU

SNYR

SPIR

Spruce Power Holding Corporation Class A Common Stock

SPRU

SYTA

TLPH

TTGT

VATE

VENU

VERO

VNRX

VVOS

WKHS

WPRT

WRAP

XPON

Earnings Scheduled For March 31, 2025

BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate BioLine Rx to report an earnings per share (EPS) of $0.00.
Anticipation surrounds BioLine Rx's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.03 in the last quarter, leading to a 1.66% increase in the share price on the following day.
Here's a look at BioLine Rx's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.10</td>
<td>-0.14</td>
<td>-0.29</td>
<td>-0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.07</td>
<td>0</td>
<td>-0.01</td>
<td>-0.15</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>9.0%</td>
<td>-4.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1743177697_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of BioLine Rx were trading at $3.19 as of March 27. Over the last 52-week period, shares are down 90.93%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/BLRX/earnings">To track all earnings releases for BioLine Rx visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: BioLine Rx's Earnings Preview

<a href="https://patentcenter.uspto.gov/applications/18270521/ifw/docs">https://patentcenter.uspto.gov/applications/18270521/ifw/docs</a>
<figure class="image"><img src="https://pbs.twimg.com/media/GijdKA7bIAAfCgm?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GijdKA8bwAAhU72?format=jpg&amp;name=small" alt="Image" /></figure><figure class="image"><img src="https://pbs.twimg.com/media/GijdKA8bUAE26DK?format=jpg&amp;name=900x900" alt="Image" /></figure>

Biotech

General

BioLineRx Ltd Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITION OF BL-8040 (FOR THE TREATMENT OF CANCER)"

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Guidance

Management

BioLineRx Outlines Vision For 2025: Plans New Oncology/Rare Disease In-Licensing, 1-For-40 Reverse Stock Split To Meet Nasdaq Compliance, $29.5M Cash, Runway Through H2 2026

<h3>Gainers</h3>
<ul>
<li>AnaptysBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) shares moved upwards by 29.7% to $19.5 during Friday's pre-market session. The market value of their outstanding shares is at $593.3 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock rose 25.88% to $0.09. The company's market cap stands at $1.4 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) stock increased by 18.74% to $1.14. The company's market cap stands at $6.8 million. </li>
<li>Immuron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRN#NASDAQ">IMRN</a>) stock moved upwards by 18.65% to $2.35. The company's market cap stands at $13.3 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) stock increased by 14.36% to $1.99. The company's market cap stands at $6.3 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares rose 13.66% to $1.83. The market value of their outstanding shares is at $21.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) shares fell 21.6% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $12.7 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock declined by 17.78% to $0.31. The market value of their outstanding shares is at $1.5 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) shares declined by 12.29% to $0.15. The market value of their outstanding shares is at $11.9 million. </li>
<li>PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) shares decreased by 7.69% to $16.7. The market value of their outstanding shares is at $399.8 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock fell 7.17% to $3.11. The company's market cap stands at $2.1 million. </li>
<li>QT Imaging Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTI#NASDAQ">QTI</a>) shares declined by 6.88% to $0.49. The company's market cap stands at $10.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

ANAB

CHRO

GCTK

IMRN

MBRX

PRTC

SCPX

12 Health Care Stocks Moving In Friday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining around 1% on Friday.
The Dow traded up 0.99% to 43,580.17 while the NASDAQ rose 1.81% to 19,688.08. The S&amp;P 500 also rose, gaining, 1.25% to 6,011.81.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 2.3% on Friday.
In trading on Friday, health care shares fell by 0.1%.
Top Headline
State Street Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) posted better-than-expected fourth-quarter earnings on Friday.
The company reported fourth quarter adjusted earnings per share of $2.60, beating the street view of $2.43. Quarterly sales of $3.412 billion (+12%) outpaced the analyst consensus estimate of $3.320 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 54% to $31.57 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 42% to $2.73 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Qorvo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares were also up, gaining 14% to $83.60 following a WSJ report indicating activist investor Starboard Value has acquired a 7.7% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 20% to $0.30 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 19% to $0.098 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>J B Hunt Transport Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) was down, falling 7% to $174.30 after the company reported fourth-quarter EPS below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.6% to $78.23 while gold traded down 0.1% at $2,749.20.
Silver traded down 1.8% to $31.145 on Friday, while copper fell 1.8% to $4.3635.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 surged 0.69%, Germany's DAX 40 gained 1.20% and France's CAC 40 gained 0.98%. Spain's IBEX 35 Index rose 0.64%, while London's FTSE 100 gained 1.35%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

Equities

Eurozone

Commodities

Markets

Trading Ideas

JBHT

NUKK

QRVO

Nasdaq Surges Over 300 Points; State Street Earnings Top Views

U.S. stocks traded higher midway through trading, with the S&amp;P 500 gaining around 1% on Friday.
The Dow traded up 0.86% to 43,524.83 while the NASDAQ rose 1.46% to 19,620.72. The S&amp;P 500 also rose, gaining, 1% to 5,996.98.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Information technology shares surged by 1.8% on Friday.
In trading on Friday, health care shares rose by just 0.1%.
Top Headline
Fastenal Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) reported weaker-than-expected fourth-quarter earnings.
Fastenal reported sales growth of 3.7% year-over-year to $1.825 billion, missing the consensus of $1.844 billion. The company's fourth-quarter EPS was 46 cents, missing the estimate of 48 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 62% to $33.26 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 49% to $2.86 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Qorvo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) shares were also up, gaining 13% to $83.31 following a WSJ report indicating activist investor Starboard Value has acquired a 7.7% stake in the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 27% to $0.27 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 21% to $0.096 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>J B Hunt Transport Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) was down, falling 7% to $173.60 after the company reported fourth-quarter EPS below estimates.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $78.28 while gold traded down 0.1% at $2,748.00.
Silver traded down 1.8% to $31.160 on Friday, while copper fell 1.4% to $4.3780.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 0.74%, Germany's DAX 40 gained 1.15% and France's CAC 40 gained 1.06%. Spain's IBEX 35 Index rose 0.50%, while London's FTSE 100 gained 1.58%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

Intraday Update

FAST

S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 300 points on Friday.
Following the market opening Friday, the Dow traded up 0.76% to 43,482.39 while the NASDAQ rose 1.36% to 19,601.89. The S&amp;P 500 also rose, gaining, 0.88% to 5,989.58.
Check This Out: <a href="https://www.benzinga.com/25/01/43051869/top-3-defensive-stocks-that-could-blast-off-this-quarter">Top 3 Defensive Stocks That Could Blast Off This Quarter</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 1.4% on Friday.
In trading on Friday, utilities shares fell by 0.1%.
Top Headline
U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares shot up 80% to $36.99 after the company announced it resolved its Nasdaq delisting notice and is now achieving compliance with the listing standards.</li>
<li>Shares of Versus Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VS#NASDAQ">VS</a>)got a boost, surging 45% to $2.8792 after the company announced expansion into the Brazilian market as part of its strategy to grow its international footprint.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares were also up, gaining 43% to $0.3058.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Scorpius Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#NYSE">SCPX</a>) shares dropped 26% to $0.2783 after the company announced its board approved a 1-for-20 reverse stock split.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 25% to $0.0915 after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) was down, falling 17% to $0.1419.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $78.59 while gold traded down 0.2% at $2,745.00.
Silver traded down 1.7% to $31.185 on Friday, while copper fell 1.3% to $4.3825.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 0.8%, Germany's DAX 40 gained 1.2% and France's CAC 40 gained 1.2%. Spain's IBEX 35 Index rose 0.7%, while London's FTSE 100 gained 1.5%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 falling 0.31%, China's Shanghai Composite Index gaining 0.18%, Hong Kong's Hang Seng Index climbing 0.31% and India's BSE Sensex falling 0.55%.
Economics
<ul>
<li>U.S. industrial production rose by 0.9% in December, topping market estimates of a 0.3% increase.</li>
<li>Housing starts rose by 15.8% from the previous month to an annualized rate of 1.499 million units in December.</li>
<li>Building permits declined by 0.7% to an annualized rate of 1.483 million in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43055377/how-to-earn-500-a-month-from-3m-stock-ahead-of-q4-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q4 Earnings</a></li>
</ul>

Dow Jumps Over 300 Points; US Industrial Production Beats Estimates

WIIM

BioLineRx shares are trading lower after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.

The change in exchange ratio for the ADSs will have the same effect as a 1-for-40 reverse stock split of the ADSs, reducing the number of outstanding ADSs from 142,340,133 to 3,558,503 ADSs.&nbsp;

BioLineRx Reports Change To Ratio Of American Depositary Shares To Ordinary Shares; Change In Exchange Ratio To Have Same Effect As 1-For-40 Reverse Stock Split

Shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) rose sharply in today's pre-market trading after the company announced <a href="https://www.benzinga.com/quote/TSM">fourth-quarter results</a>.
Taiwan Semiconductor Mfg. said net profit climbed 57% year-over-year to a record T$374.68 billion ($11.38 billion).
TSMC shares gained 4.7% to $216.61 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) gained 83.1% to $1.63 in pre-market trading after gaining 8% on Wednesday.</li>
<li>Powell Max Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) gained 67.8% to $2.45 in pre-market trading after the company announced acquisition plans and is targeting firms with between $1 million and $5 million in revenue to expand into the Hong Kong and Asian financial communications market.</li>
<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) rose 40.1% to $0.1458 in pre-market trading after dipping 15% on Wednesday. BioLineRx recently announced a $10 million registered direct offering.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) gained 39.3% to $3.28 in pre-market trading after falling 4% on Wednesday.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) rose 22.5% to $0.1342 in pre-market trading after dipping 14% on Wednesday. AEON Biopharma recently announced closing of $20.0 million underwritten public offering</li>
<li>DouYu International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) rose 17.4% to $14.43 in pre-market trading after the company named Ms. Simin Ren as co-CEO and announced a special cash dividend of $9.94/ADS.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 15.1% to $3.90 in pre-market trading after the company announced a chief executive transition. BigBear.ai has appointed Kevin McAleenan as CEO and a member of the company's board, effective as of Wednesday. McAleenan will replace Mandy Long, who is transitioning to an advisory role.</li>
<li>Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) gained 12.8% to $0.2620 in pre-market trading.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) gained 10.3% to $12.74 in pre-market trading after surging 55% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Transcontinental Realty Investors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCI#NYSE">TCI</a>) shares fell 31.8% to $19.01 in pre-market trading.</li>
<li>Algorhythm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) fell 20.3% to $0.04 in pre-market trading after dipping 35% on Wednesday.</li>
<li>GlucoTrack, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) dipped 20.3% to $0.0630 in pre-market trading following a 35% decline on Wednesday.</li>
<li>Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) declined 15.5% to $3.19 in pre-market trading. Sonim Technologies shares gained 10% on Wednesday after Orbic North America announced an agreement in principle to acquire a substantial equity ownership position in the company.</li>
<li>C&amp;F Financial Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFFI#NASDAQ">CFFI</a>) shares fell 15.3% to $60.01 in pre-market trading.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) fell 14.7% to $14.01 in pre-market trading after gaining 5% on Wednesday. SI-BONE recently reported preliminary fourth-quarter revenue results.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) shares dipped 12.9% to $0.5991 in pre-market trading. LuxUrban Hotels recently issued FY25 revenue guidance.</li>
<li>Sangoma Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANG#NASDAQ">SANG</a>) fell 12.1% to $6.19 in today's pre-market trading after gaining 5% on Wednesday.</li>
<li>ANI Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) shares tumbled 11.6% to $50.01 in pre-market trading. ANI Pharmaceuticals recently issued preliminary fourth quarter and 2024 financial results and preliminary 2025 outlook.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) fell 11.3% to $1.38 in pre-market trading after the company announced the pricing of $5.0 million public offering.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

ANIP

BBAI

CFFI

DOYU

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Regional Health Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) stock increased by 183.9% to $4.4 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. </li>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares moved upwards by 38.32% to $1.01. The market value of their outstanding shares is at $22.2 million. </li>
<li>Microbot Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) shares increased by 29.9% to $2.78. The market value of their outstanding shares is at $47.0 million. </li>
<li>Renovaro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>) stock moved upwards by 23.11% to $1.14. The company's market cap stands at $180.9 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares moved upwards by 21.38% to $2.1. The market value of their outstanding shares is at $24.1 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares rose 18.86% to $0.15. The market value of their outstanding shares is at $8.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock declined by 71.6% to $0.16 during Monday's pre-market session. The market value of their outstanding shares is at $6.4 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock fell 37.41% to $0.18. The market value of their outstanding shares is at $2.9 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) stock fell 29.0% to $0.19. The market value of their outstanding shares is at $16.3 million. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock fell 24.13% to $0.23. The company's market cap stands at $2.3 million. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) shares fell 18.31% to $1.45. The company's market cap stands at $8.9 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock decreased by 17.93% to $0.45. The market value of their outstanding shares is at $2.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACON

AYTU

CNSP

EKSO

MBOT

RENB

12 Health Care Stocks Moving In Monday's Pre-Market Session

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.
The Dow traded up 0.08% to 42,765.84 while the NASDAQ gained 1.05% to 19,828.63. The S&amp;P 500 also rose, gaining, 0.59% to 5,976.38.
Check This Out: <a href="https://www.benzinga.com/25/01/42810054/this-analyst-with-85-accuracy-rate-sees-around-16-downside-in-tesla-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 2.1% on Monday.
In trading on Monday, utilities shares fell by 0.6%.
Top Headline
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) shares shot up 131% to $3.5824. Regional Health announced plans to merge with SunLink in a $10 million preferred stock deal.</li>
<li>Shares of SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>)got a boost, surging 108% to $1.10 after announcing the publication of a European patent application for binge behavior.</li>
<li>fuboTV Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NASDAQ">FUBO</a>) shares were also up, gaining 235% to $4.83 after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a virtual MVPD company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares dropped 67% to $0.1884 after the company announced the pricing of approximately $20.0 million underwritten public offering.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 42% to $0.1586 after the company reported a $10 million registered direct offering.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was down, falling 41% to $0.0868 after the company reported the pricing of $4.4 million registered direct offering.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $73.92 while gold traded down 0.2% at $2,648.90.
Silver traded up 1.9% to $30.640 on Monday, while copper rose 2.4% to $4.1695.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.95%, Germany's DAX 40 gained 1.56% and France's CAC 40 climbed 2.24%. Spain's IBEX 35 Index rose 1.34%, while London's FTSE 100 rose 0.31%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 falling 1.47%, China's Shanghai Composite Index falling 0.14%, Hong Kong's Hang Seng Index declining 0.36% and India's BSE Sensex falling 1.59%.
Economics
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42809598/progress-software-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Progress Software Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

BHAT

FUBO

SPRC

Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet

U.S. stocks traded higher midway through trading, with the S&amp;P 500 jumping more than 1% on Monday.
The Dow traded up 0.51% to 42,949.22 while the NASDAQ gained 1.78% to 19,970.13. The S&amp;P 500 also rose, gaining, 1.09% to 6,007.42.
Check This Out: <a href="https://www.benzinga.com/25/01/42810054/this-analyst-with-85-accuracy-rate-sees-around-16-downside-in-tesla-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 85% Accuracy Rate Sees Around 16% Downside In Tesla &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 2.3% on Friday.
In trading on Friday, utilities shares fell by 1.2%.
Top Headline
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) shares shot up 171% to $4.2050. Regional Health announced plans to merge with SunLink in a $10 million preferred stock deal.</li>
<li>Shares of SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>)got a boost, surging 160% to $1.3701 after announcing the publication of a European patent application for binge behavior.</li>
<li>fuboTV Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NASDAQ">FUBO</a>) shares were also up, gaining 153% to $3.6610 after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a virtual MVPD company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares dropped 67% to $0.1894 after the company announced the pricing of approximately $20.0 million underwritten public offering.</li>
<li>Shares of BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) were down 39% to $0.1659 after the company reported a $10 million registered direct offering.</li>
<li>Blue Hat Interactive Entertainment Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) was down, falling 39% to $0.0900 after the company reported the pricing of $4.4 million registered direct offering.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $74.75 while gold traded down 0.1% at $2,651.60.
Silver traded up 2.2% to $30.715 on Monday, while copper rose 3.1% to $4.1980.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.54%, Germany's DAX 40 gained 1.05% and France's CAC 40 climbed 1.68%. Spain's IBEX 35 Index rose 0.82%, while London's FTSE 100 fell 0.06%.
Asia Pacific Markets
Asian markets closed lower on Monday, with Japan's Nikkei 225 falling 1.47%, China's Shanghai Composite Index falling 0.14%, Hong Kong's Hang Seng Index declining 0.36% and India's BSE Sensex falling 1.59%.
Economics
The S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42809598/progress-software-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Progress Software Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

S&P Jumps 1%; Regional Health Properties Shares Spike Higher

Small Cap

Press Releases

BioLineRx to Report Third Quarter 2024 Results on November 25, 2024

BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.

BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value

Health Care

Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors

Offerings

BioLineRx Announces $10 Million Registered Direct Offering

BioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares

Comments

BioLine Rx

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO